PDCD1 and neoplasm: In the basic research of breast cancer, it has been found that PD-1/PD-L1 inhibitors combined with radiotherapy have a stronger anti-tumor effect than single-mode treatment, and the survival time of mice is significantly higher than that of the control group (11, 12).